# TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

> **NCT01134393** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 502 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** telmisartan/amlodipine

## Key facts

- **NCT ID:** NCT01134393
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-05
- **Final completion:** —
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2014-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134393, "TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01134393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*